Antiviral activity of lambda - carrageenan prepared from red seaweed [Gigartina skottsbergii] against BoHV-1 and SuHV-1

The antiviral effect of polysaccharides has been known for many years. Carrageenans are considered a good alternative for the prevention of a wide range of diseases, mainly caused by enveloped viruses. The advantages lie on their high availability, low cost and low induction of resistance. The aim o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Otros Autores: Diogo, Jésica V., Galdo Novo, Sabrina, González, Marcelo J., Ciancia, Marina, Bratanich, Ana C.
Formato: Artículo
Lenguaje:Español
Materias:
Acceso en línea:http://ri.agro.uba.ar/files/intranet/articulo/2015diogo.pdf
LINK AL EDITOR
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 02733cab a22005777a 4500
001 AR-BaUFA000832
003 AR-BaUFA
005 20220811142058.0
008 181208t2015 |||||o|||||00||||spa d
999 |c 47228  |d 47228 
999 |d 47228 
022 |a 0034-5288 
024 |a 10.1016/j.rvsc.2014.11.010 
040 |a AR-BaUFA  |c AR-BaUFA 
245 1 0 |a Antiviral activity of lambda - carrageenan prepared from red seaweed [Gigartina skottsbergii] against BoHV-1 and SuHV-1 
520 |a The antiviral effect of polysaccharides has been known for many years. Carrageenans are considered a good alternative for the prevention of a wide range of diseases, mainly caused by enveloped viruses. The advantages lie on their high availability, low cost and low induction of resistance. The aim of this study was to evaluate the sensitivity of two viral pathogens of veterinary interest to the presence of lambda-carrageenan. This is the first report of a lambda-carrageenan having antiviral activity against animal viruses belonging to the Alphaherpesvirinae subfamily, BoHV-1 [bovine herpesvirus type 1] strain Cooper and SuHV-1 [suid herpesvirus type 1] strain Bartha. Lambda-carrageenan was able to reduce infectivity of both viruses with a more pronounced effect against BoHV-1. These results proved, as previously shown for human herpes virus type 1, that these compounds could be used as potential antiviral agents in the veterinary field. 
650 |2 Agrovoc  |9 26 
653 0 |a VIRUS STRAIN 
653 0 |a VIRUS INFECTIVITY 
653 0 |a UNCLASSIFIED DRUG 
653 0 |a SUID HERPESVIRUS TYPE 1 
653 0 |a SUID HERPESVIRUS 1 
653 0 |a SIMPLEXVIRUS 
653 0 |a SEAWEED 
653 0 |a NONHUMAN 
653 0 |a LAMBDA CARRAGEENAN 
653 0 |a HUMAN HERPESVIRUS 1 
653 0 |a HERPESVIRUS 
653 0 |a HERPESVIRIDAE 
653 0 |a GIGARTINA SKOTTSBERGII 
653 0 |a DRUG MECHANISM 
653 0 |a CONTROLLED STUDY 
653 0 |a CONCENTRATION RESPONSE 
653 0 |a CARRAGEENAN 
653 0 |a BOVINE HERPESVIRUS 1 
653 0 |a ANTIVIRAL ACTIVITY 
653 0 |a ANTIVIRAL 
653 0 |a ANIMALIA 
653 0 |a ANIMAL CELL 
653 0 |a ALPHAHERPESVIRINAE 
700 1 |a Diogo, Jésica V.  |9 70377 
700 1 |a Galdo Novo, Sabrina  |9 70378 
700 1 |a González, Marcelo J.  |9 70379 
700 1 |9 46099  |a Ciancia, Marina 
700 1 |a Bratanich, Ana C.  |9 70380 
773 |t Research in Veterinary Science  |g vol.98 (2015), p.142-144 
856 |u http://ri.agro.uba.ar/files/intranet/articulo/2015diogo.pdf  |i En reservorio  |q application/pdf  |f 2015diogo  |x MIGRADOS2018 
856 |u https://www.elsevier.com/  |x MIGRADOS2018  |z LINK AL EDITOR 
942 0 0 |c ARTICULO 
942 0 0 |c ENLINEA 
976 |a AAG